Skip to content

Telehealth Virtual Reality Exergaming for Spinal Cord Injury

Telehealth Virtual Reality Exergaming and Peer Networking Among People With Spinal Cord Injury

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05318079
Enrollment
0
Registered
2022-04-08
Start date
2022-04-01
Completion date
2022-04-13
Last updated
2022-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

This pilot feasibility study aims to test whether youth and adults with spinal cord injury can use a group virtual reality gaming intervention to exercise. A second purpose is to examine whether there are potential benefits to cardiometabolic health and psychosocial health.

Detailed description

There are three purposes to this study. The first purpose is to quantify feasibility through telemonitored exercise data: total play time, moderate exercise time, playtime with others, and compliance to the data collections. These variables will be compared against a priori criteria for acceptability. These variables will help determine whether modifications to the intervention protocol are necessary. The second purpose is to qualitatively interview participants to explain underlying behavioral mechanisms that affect their participation in the program. This information will be used to explain how to improve implementation issues identified in Aim 1. The third aim is to explore the potential effects of the program on self-reported psychosocial health and quality of life, hand-grip strength, and cardiometabolic health (blood cholesterol, lipids, pressure, and insulin) measured via home dried blood spot test.

Interventions

Peer-to-peer gaming.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* medical diagnosis of traumatic spinal cord injury (determined by International Classification of Disease \[ICD\] codes) * a caregiver to support the participant if the participant is a child (\<18 years of age) * access to a Wi-Fi Internet connection in the home

Exclusion criteria

* physically active (defined as \>150 minutes per week of moderate-to-vigorous intensity exercise in a typical week) * cannot use the arms for exercise or operate the controller buttons using their fingers * complete blindness or deafness * recent myocardial infarction or electrocardiography changes, complete heart block, acute congestive heart failure, unstable angina, and uncontrolled severe hypertension \[BP \>/= 180/110 mmHg\] * prone to seizures

Design outcomes

Primary

MeasureTime frameDescription
Total play timeIntervention Week 1 - Week 8Percentage of the 300 minutes of prescribed play per week across the intervention.
Total exercise timeIntervention Week 1 - Week 8Moderate exercise minutes where prescription was met (percent of prescription achieved: weeks where the ≥90 minutes of moderate intensity exercise per week was achieved across the intervention, divided by total weeks).
Playtime with othersIntervention Week 1 - Week 8Measured by the number of play sessions with other players (online multiplayer and/or peer-gaming). This number will be totaled across the 8-week intervention and divided by 16 (the exercise prescription of 2 x per week of multiplayer gaming).
Compliance to baseline data collectionWeek 0Number of pre data collections completed, converted into a percentage dividing by the total possible.
Compliance to post data collectionsWeek 9Number of pre data collections completed, converted into a percentage dividing by the total possible.

Secondary

MeasureTime frameDescription
Changes in high sensitivity C-reactive protein (hsCRP)Week 0, Week 5, Week 9Changes in high sensitivity C-reactive protein measured via blood spot test across the intervention.
Changes in hemoglobin A1cWeek 0, Week 5, Week 9Changes in hemoglobin A1c measured via blood spot test across the intervention.
Changes in fasting insulinWeek 0, Week 5, Week 9Changes in fasting insulin levels measured via blood spot test across the intervention.
Hospital Anxiety and Depression ScaleWeek 0, Week 5, Week 9The Hospital Anxiety and Depression Scale is a 14-item self-report measure that provides separate scores for anxiety and depression. Hospital Anxiety and Depression Scale is a common clinical measure that has strong psychometric properties. Scores range from 0 to 42, where a higher score represents a worse level of depression.
Changes in total cholesterolWeek 0, Week 5, Week 9Changes in total cholesterol measured via blood spot test across the intervention.
Changes in low-density lipoprotein (LDL)Week 0, Week 5, Week 9Changes in low-density lipoprotein via blood spot test across the intervention.
Changes in high-density lipoprotein (LDL)Week 0, Week 5, Week 9Changes in high-density lipoprotein via blood spot test across the intervention.
Changes in fasting triglyceridesWeek 0, Week 5, Week 9Changes in fasting triglycerides levels measured via blood spot test across the intervention.
World Health Organization Quality of LifeWeek 0, Week 5, Week 9The World Health Organization Quality of Life is a self-report questionnaire with 26 items that cover 5 dimensions: physical health (7 items); psychological health (6 items); social relationships (3 items); environment (8 items); and overall quality of life (2 items). Raw scores are calculated for each domain on a lilkert scale of 1-5 (low domain score of 3, max domain raw score of 40. Raw scores are then multiplied by 4 to transform the raw score into a scaled score. Higher scores represent higher perceived ratings of quality of life.
Functional Grip StrengthWeek 0, Week 5, Week 9Grip strength will be measured as an indicator of global muscular strength, using a low-cost hand-held dynamometer.
Critical factors that affected adherenceIntervention Week 9Participants will undergo one-on-one, semi-structured interviews after the intervention to identify critical factors that affected their participation to the intervention.
Changes in blood pressureWeek 0, Week 5, Week 9Changes in resting home-blood pressure (systolic and diastolic ) measured via blood pressure cuff across the intervention.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026